Evidence map›Paper›PMID 38216923›Full record

ReviewMalaria journal2024

A perspective on Oxford's R21/Matrix-M™ malaria vaccine and the future of global eradication efforts.

Nicholas Aderinto, Gbolahan Olatunji, Emmanuel Kokori, Sodeeq Sikirullahi, John Ehi Aboje, Rebecca Ebokondu Ojabo

Abstract readReview
In one paragraph

Review in Malaria journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Computational vaccine development against protozoa.Computational and structural biotechnology journal · 2025
    Review
  15. Article
  16. Updating a Rural Clinic in Tiburón, Haiti.HCA healthcare journal of medicine · 2025
    Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nicholas AderintoDepartment of Medicine and Surgery, Ladoke Akintola University Teaching Hospital, PMB 5000, Ogbomoso, Nigeria. Nicholasoluwaseyi6@gmail.com.
Gbolahan OlatunjiDepartment of Medicine and Surgery, University of Ilorin, Ilorin, Nigeria.
Emmanuel KokoriDepartment of Medicine and Surgery, University of Ilorin, Ilorin, Nigeria.
Sodeeq SikirullahiDepartment of Medicine and Surgery, University of Ilorin, Ilorin, Nigeria.
John Ehi AbojeCollege of Health Sciences, Benue State University, Makurdi, Benue, Nigeria.
Rebecca Ebokondu OjaboAfe Babalola University College of Medicine and Health Sciences, Ado-Ekiti, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malaria affects millions of lives annually, particularly in tropical and subtropical regions. Despite being largely preventable, 2021 witnessed 247 million infections and over 600,000 deaths across 85 countries. In the ongoing battle against malaria, a promising development has emerged with the endorsement by the World Health Organization (WHO) of the R21/Matrix-M

Indexed as

MalariaMalaria VaccinesChildChild, PreschoolHumansMalaria VaccinesEradicationGlobal HealthMalariaR21/Matrix-MVaccineWHO

Identifiers

PMID38216923
PMCPMC10787413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.